The symposium is relevant for the scientific community within various relevant areas including structural biology, pharmacology, computational and medicinal chemistry. It aims to provide an overview of the current situation, challenges and future perspectives within structure-based drug discovery. The program gathers keynote talks from both academia and the pharmaceutical industry, covering all the areas of structure – based drug design with special focus on fragment based lead discovery (FBLD).
The symposium is open for registration to scientists, both PhD students, post-docs and senior researchers. The deadline to register for the symposium is the 4th of September and for the full course on the 21st of August.
Further information HERE